|
|
| Research article summary (published 30 Aug 2009): |
Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene.
Full Abstract
The relationship between weight reduction after sibutramine treatment and a single nucleotide polymorphism, rs5443 (C825T), in the guanine nucleotide binding protein beta polypeptide 3 (GNB3) gene is currently inconsistent. In this study, we aimed to reassess whether the GNB3 rs5443 single nucleotide polymorphism could influence weight reduction and body composition change under sibutramine therapy in 131 obese Taiwanese patients. By comparing the sibutramine and placebo groups with analysis of covariance, our data showed a strong effect of sibutramine on weight reduction (7.4+/-1.4 vs. 3.4+/-1.2 kg; P<0.001) and on body fat percentage loss (4.2+/-0.1 vs. 2.1+/-0.1%; P<0.001) in the combined TT+TC carriers. In contrast, sibutramine caused no significant additional effect on weight loss (P = 0.078) or on body fat percentage loss (P = 0.441) in homozygous C allele carriers.
Author information
Author/s: Hsiao, Dun-Jen (DJ); Wu, Lawrence Shih-Hsin (LS); Huang, Shih-Yi (SY); Lin, Eugene (E);
Affiliation: College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.
Journal and publication information
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Journal: Pharmacogenetics and genomics (Pharmacogenet Genomics), published in United States. (Language: eng)
Reference: 2009-Sep; vol 19 (issue 9) : pp 730-3
Dates: Created 2009/09/04; Completed 2009/10/09;
PMID: 19687782, status: MEDLINE (last retrieval date: 10/9/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- [A randomized, double-blind, placebo-controlled, multicenter study on sibutramine in over-weighted and obese subjects]
30 Aug 2001 - Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
29 Apr 2006 - Long-term medication use and weight loss maintenance: an observational study.
29 Sep 2001 - Evaluation of efficacy, reliability, and tolerability of sibutramine in obese patients, with an echocardiographic study.
29 Apr 2002 - Diet drug helps keep weight off.
30 Jan 2001 - [Patients with type III obesity given sibutramine 15 mg/day lose weight in amounts proportional to those in types I and II, but waist circumferences does not decrease proportionally]
27 Feb 2007 - Weight loss and quality of life improvement in obese subjects treated with sibutramine: a double-blind randomized multicenter study.
13 Mar 2007 - Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
30 Jan 2005 - Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
2 Jun 2007 - Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women.
29 Nov 2004
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.